Analyst Ratings for Bellerophon Therapeutics (BLPH)
BLPH Rating Summary
BLPH Price Target Summary
- Highest: $2.00 (H.C. Wainwright)
- Lowest: $2.00 (H.C. Wainwright)
- Average: $2.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.00 (+1900%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Avg. $ Target:
$2.00 (+1900%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/6/2023 | Laidlaw | Yale Jen | Downgrade | Hold (Buy) |
N/A (N/A) |
7.06 (0.10) |
-98.58% | Details |
| 6/5/2023 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
7.06 (0.10) |
-98.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
